Cancer/testis antigen expression in human mesenchymal stem cells: down-regulation of SSX impairs cell migration and matrix metalloproteinase 2 expression.
about
Antimetastatic gene expression profiles mediated by retinoic acid receptor beta 2 in MDA-MB-435 breast cancer cells.KIAA1114, a full-length protein encoded by the trophinin gene, is a novel surface marker for isolating tumor-initiating cells of multiple hepatocellular carcinoma subtypesIdentification of target genes for wild type and truncated HMGA2 in mesenchymal stem-like cells.Regulation of cancer germline antigen gene expression: implications for cancer immunotherapy.Expression of the cancer/testis antigen NY-ESO-1 in primary and metastatic malignant melanoma (MM)--correlation with prognostic factorsDNA vaccines encoding altered peptide ligands for SSX2 enhance epitope-specific CD8+ T-cell immune responsesThe SSX family of cancer-testis antigens as target proteins for tumor therapy.Derepression of Cancer/testis antigens in cancer is associated with distinct patterns of DNA hypomethylation.Inhibition of the receptor tyrosine kinase ROR1 by anti-ROR1 monoclonal antibodies and siRNA induced apoptosis of melanoma cellsExpression patterns of cancer-testis antigens in human embryonic stem cells and their cell derivatives indicate lineage tracksOncogenic functions of the cancer-testis antigen SSX on the proliferation, survival, and signaling pathways of cancer cells.A gene expression based predictor for high risk myeloma treated with intensive therapy and autologous stem cell rescue.Predictive and prognostic effect of CD133 and cancer-testis antigens in stage Ib-IIIA non-small cell lung cancer.Cancer/testis antigens and urological malignanciesPotential use of vaccines in the primary prevention of breast cancer in high-risk patients.Directions in the immune targeting of cancer: lessons learned from the cancer-testis Ag NY-ESO-1.Restriction of GAGE protein expression to subpopulations of cancer cells is independent of genotype and may limit the use of GAGE proteins as targets for cancer immunotherapy.Expression of cancer testis antigens in human BRCA-associated breast cancers: potential targets for immunoprevention?Role of gene methylation in antitumor immune response: implication for tumor progression.Down regulation of SPAG9 reduces growth and invasive potential of triple-negative breast cancer cells: possible implications in targeted therapy.Immunohistochemical assessment of NY-ESO-1 expression in esophageal adenocarcinoma resection specimensMAGEC2, an epithelial-mesenchymal transition inducer, is associated with breast cancer metastasis.Cancer-germline antigen vaccines and epigenetic enhancers: future strategies for cancer treatment.Expression of cancer-testis genes in brain tumors: implications for cancer immunotherapy.Treatment of adult soft tissue sarcoma: old concepts, new insights, and potential for drug discovery.Cancer-testis genes as candidates for immunotherapy in breast cancer.T cell-based targeted immunotherapies for patients with multiple myeloma.Targeting Tumor Initiating Cells through Inhibition of Cancer Testis Antigens and Notch Signaling: A Hypothesis.New York esophageal squamous cell carcinoma-1 and cancer immunotherapy.Synovial sarcoma is a gateway to the role of chromatin remodeling in cancer.Prediction-Oriented Marker Selection (PROMISE): With Application to High-Dimensional Regression.Sperm-associated antigen 9 (SPAG9) promotes the survival and tumor growth of triple-negative breast cancer cells.Applying Subtractive Hybridization Technique to Enrich and Amplify Tumor-Specific Transcripts of Esophageal Squamous Cell Carcinoma.SSX2 regulates focal adhesion but does not drive the epithelial to mesenchymal transition in prostate cancer.Cancer/Testis Antigens: Expression, Regulation, Tumor Invasion, and Use in Immunotherapy of Cancers.Enrichment of putative prostate cancer stem cells after androgen deprivation: upregulation of pluripotency transactivators concurs with resistance to androgen deprivation in LNCaP cell lines.HDAC1-mSin3a-NCOR1, Dnmt3b-HDAC1-Egr1 and Dnmt1-PCNA-UHRF1-G9a regulate the NY-ESO1 gene expression.Identification and functional characterization of glioma-specific promoters and their application in suicide gene therapy.Knockdown of cancer testis antigens modulates neural stem cell marker expression in glioblastoma tumor stem cells.Cancer-testis antigens MAGE-C1/CT7 and MAGE-A3 promote the survival of multiple myeloma cells.
P2860
Q24816725-7873F7C3-E55C-4126-AB8C-09591711E873Q33576807-652A1904-DC43-4632-A79C-E884F07CAB57Q33615450-01835F87-AB4D-4522-AAF1-301A85990CC6Q33957165-C2FDF56B-4008-4AB9-862A-E6A19A187D45Q34111725-27C00358-6CB6-430F-977B-E978F1A5175FQ34127323-B49778EF-418B-4963-9795-BD751B663AEAQ34146229-DBA73225-8497-4F0C-ACA2-8E95BB4431C6Q34632716-B6452D56-4792-4168-B152-3E32F134C37FQ34674715-38F9CA2A-4BD4-482E-B14A-0DEB6F467D91Q35116913-342412E0-6525-4379-BD76-C6ED71FE0E37Q35161225-164523F0-EB10-43F6-AA56-530DBA433143Q35651050-B09F729C-0D7F-420F-A917-AF574BCB6036Q35854237-C733F34D-0D31-456A-9373-EB45C719CFA0Q36337004-A1BAFE92-2D17-4136-84D6-3D1C1AB02091Q36449263-AD5A260F-7BB2-41E0-9C2A-D76963D8EB81Q36471827-92F9B94B-350B-4762-B7E4-CB05311CFA64Q36614408-63D256C4-7CA4-4160-BC14-FF5652E183BFQ36918233-BFF1EB7E-E03D-468B-BAB3-8C9E8ED75C0BQ37132658-EF91F6B7-8C07-42F4-BC61-C7FC165E3C98Q37359890-CE56843E-1C9A-455F-9A80-9590ED19CB22Q37697566-17A53A47-6727-49CF-9D3F-DCADB41D8F5EQ37699127-39F87A1A-31B2-4FAF-B1B9-0AAC807233F6Q37737327-D113C908-8E6E-4F2E-A32A-6BFABC5B483FQ37965751-05849250-7F37-4A23-A62E-618576C77683Q38000323-D3764144-2511-4EED-BDE2-28D50CF5F3CCQ38184648-599D2198-7934-43EF-86E6-FD14371B81A0Q38246639-C92B8F07-5663-4680-B0A9-86272E8FCCB5Q38435424-8F6AE960-0F45-433A-8ABB-FC72439D39E5Q38445350-A98381BD-6FDA-4E6A-BDE6-01D099F8CE13Q38567366-46352866-A96E-41F8-A3AA-8E065B4B8DCFQ38635859-55143AEC-019A-4C2C-841C-87A6C82CBBFFQ38756311-26350AF8-A428-44CE-ABDF-2FCA54B26ECFQ38841320-397E2325-D71B-4385-83DC-1571714239FFQ38856316-6ABAB4C2-F4CC-4491-B525-BDB04D6CF759Q38948541-94C97E55-7E84-4ACD-BF31-98D780310BE1Q39144729-E6068FDF-32DC-46A3-8065-E40BFDC3859FQ39211999-16C93F23-3AEF-40F9-B96D-CC0995827C43Q39586718-2DB796FA-04BF-4919-8113-85348EEAF159Q39678731-EB4CBA86-E173-4B16-A548-E8A95E59D075Q39762419-5690DB97-1597-41EF-B456-52F41C409A05
P2860
Cancer/testis antigen expression in human mesenchymal stem cells: down-regulation of SSX impairs cell migration and matrix metalloproteinase 2 expression.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Cancer/testis antigen expressi ...... etalloproteinase 2 expression.
@en
type
label
Cancer/testis antigen expressi ...... etalloproteinase 2 expression.
@en
prefLabel
Cancer/testis antigen expressi ...... etalloproteinase 2 expression.
@en
P2093
P1433
P1476
Cancer/testis antigen expressi ...... etalloproteinase 2 expression.
@en
P2093
Bertha Brodin
Cecilia Götherström
Garth Cronwright
Katarina Le Blanc
Monika Ehnman
Pádraig Darcy
P304
P356
10.1158/0008-5472.CAN-04-1882
P407
P577
2005-03-01T00:00:00Z